by alfie | Jan 5, 2024 | news and press
< Back to Sanius content AI platform Sanius Health and primary care provider Modality Partnership announce £225m deal Sanius Health has announced a deal valued at £225 million which will see its data, research and personalised health patient AI platform leveraged...
by alfie | Dec 11, 2023 | news and press
< Back to Sanius content 7000 Research Insights into Innovations and Cutting-edge Science in Haematology: Improving Outcomes, Access and New Medicines We’re heading into the home stretch of 2023, which will be marked by one last congress for the year. This...
by alfie | Dec 11, 2023 | news and press
< Back to Sanius content Advancements in Real-World Healthcare-Focused AI | A Patient Use Case in Vaso-Occlusive Crisis Prediction As we accelerate through our AI journey in improving healthcare for patients with sickle cell disease (SCD), a core focus has been...
by alfie | Dec 7, 2023 | news and press
< Back to Sanius content Top 80 Most Influential Advocates & People in SCD 2024 Advancing developments in Sickle Cell Disease would not be possible without the unwavering support of patients and clinical colleagues around the world. The Sanius Health team would...
by purvi | Dec 1, 2023 | news and press
< Back to Sanius content Translating Real-World Wearables and Digital Self-Reporting Data to Novel Research Insights | Vaso-Occlusive Crisis Predictions and Treatment Pathway Insights in Sickle Cell Disease The onset of a vaso-occlusive crisis (VOC) is an all too...
by purvi | Dec 1, 2023 | news and press
< Back to Sanius content Generating Real-World Insights for Rare Disease Research and Clinical Trial Implications | A Case Study in AL Amyloidosis “Ultra-rare” and “incurable” – keywords that appear all too often when exploring the rare disease landscape. For...